Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 94.10
+5.50 (6.21%)
Sep 2, 2026, 3:02 PM IDT
TLV:IMED Market Cap
TLV:IMED has a market cap or net worth of 3.8 million as of September 2, 2026. Its market cap has decreased by -33.55% in one year.
Market Cap
3.80M
Enterprise Value
-4.41M
Revenue
-1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
94.10
ChartMarket Cap Chart
Since December 29, 2020, TLV:IMED's market cap has decreased from 40.32M to 3.80M, a decrease of -90.58%. That is a compound annual growth rate of -34.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.80M | -22.81% |
| Dec 31, 2025 | 4.92M | 9.43% |
| Dec 30, 2024 | 4.49M | -2.45% |
| Dec 31, 2023 | 4.61M | -19.63% |
| Dec 27, 2022 | 5.73M | -55.66% |
| Dec 30, 2021 | 12.93M | -67.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 127.48B |
| Danel (Adir Yeoshua) | 2.58B |
| Amal Holdings A.D. | 2.25B |
| BrainsWay | 1.73B |
| Purple Biotech | 18.65M |
| Erika Carmel-Tech | 18.37M |
| Nextage Therapeutics | 12.06M |
| Bio-View | 10.73M |